Seroprevalence of known and putative hepatitis markers inUnited States blood donors with ALT levels at least 120 IU per L
- 1 June 2001
- journal article
- Published by Wiley in Transfusion
- Vol. 41 (6) , 751-755
- https://doi.org/10.1046/j.1537-2995.2001.41060751.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion RecipientsVox Sanguinis, 1998
- Limited utility of alanine aminotransferase screening of hepatitis C antibody‐screened blood donorsTransfusion, 1997
- Detection of antibodies to a putative hepatitis G virus envelope proteinThe Lancet, 1997
- Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible AgentScience, 1996
- Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor StudyTransfusion, 1995
- Infectious Disease Testing for Blood TransfusionsJAMA, 1995
- Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferaseTransfusion, 1994
- Serum alanine aminotransferase (ALT) elevation in asymptomatic US air force basic trainee blood donorsDigestive Diseases and Sciences, 1993
- Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAsJournal of Virological Methods, 1993
- Prevention of Transfusion-Associated Cytomegalovirus (CMV) Infection in Neonates by Screening Blood Donors for IgM to CMVThe Journal of Infectious Diseases, 1988